For the year ending 2025-12-31.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| General and administrative expenses | 238,755 | |||
| Total operating expenses | 238,755 | |||
| Loss from operations | -238,755 | |||
| Gain on disposal of equity method investment | 1,171,760 | |||
| Relief of indebtedness income | -1,697,024 | |||
| Interest expense | 256,219 | |||
| Total other (income) expenses | 2,612,565 | |||
| Income (loss) before income taxes | 2,373,810 | |||
| Net income (loss) before equity in net loss of equity method investees | 2,373,810 | |||
| Equity in net income (loss) of equity method investees | 640 | |||
| Income from (impairment of) equity method investee, newstem | 5,432 | |||
| Net income (loss) | 2,379,882 | |||
| Basic EPS | 0.05 | |||
| Diluted EPS | 0.05 | |||
| Basic Average Shares | 46,881,475 | |||
| Diluted Average Shares | 47,795,437 | |||
NovelStem International Corp. (NSTM)
NovelStem International Corp. (NSTM)